Literature DB >> 17876305

Cardioprotection: spotlight on PKG.

M V Cohen1, J M Downey.   

Abstract

Classical ischaemic preconditioning, delayed or second window preconditioning and postconditioning are forms of cardioprotection that are dependent on cell surface receptors, intracellular signalling molecules and kinases that ultimately block formation of the mitochondrial permeability transition. The latter is presumed to cause myocardial necrosis as well as apoptosis, so prevention of its formation upon resumption of perfusion after a prolonged coronary occlusion should be cardioprotective. In all of these forms of cardioprotection, formation of cGMP and activation of protein kinase G (PKG) are recognized to be key steps in the signal transduction pathway. Burley et al. highlight the roles of cGMP and PKG in their comprehensive review. They describe the basic biology of PKG and emphasize its compartmentalization, which may be responsible for the frustration induced by assays for PKG in whole cell lysates and for the spurious conclusions about the role of PKG in cardioprotection. This review will be useful to both the novice and the seasoned investigator.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17876305      PMCID: PMC2078228          DOI: 10.1038/sj.bjp.0707453

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  6 in total

1.  Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart.

Authors:  G S Liu; J Thornton; D M Van Winkle; A W Stanley; R A Olsson; J M Downey
Journal:  Circulation       Date:  1991-07       Impact factor: 29.690

2.  Intermittent activation of bradykinin B2 receptors and mitochondrial KATP channels trigger cardiac postconditioning through redox signaling.

Authors:  Claudia Penna; Daniele Mancardi; Raffaella Rastaldo; Gianni Losano; Pasquale Pagliaro
Journal:  Cardiovasc Res       Date:  2007-03-12       Impact factor: 10.787

3.  Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.

Authors:  C E Murry; R B Jennings; K A Reimer
Journal:  Circulation       Date:  1986-11       Impact factor: 29.690

Review 4.  Protecting the acutely ischemic myocardium beyond reperfusion therapies: are we any closer to realizing the dream of infarct size elimination?

Authors:  R Tissier; M V Cohen; J M Downey
Journal:  Arch Mal Coeur Vaiss       Date:  2007-09

Review 5.  Cyclic GMP and protein kinase-G in myocardial ischaemia-reperfusion: opportunities and obstacles for survival signaling.

Authors:  D S Burley; P Ferdinandy; G F Baxter
Journal:  Br J Pharmacol       Date:  2007-08-13       Impact factor: 8.739

6.  Natriuretic peptides and nitric oxide stimulate cGMP synthesis in different cellular compartments.

Authors:  Leslie A Piggott; Kathryn A Hassell; Zuzana Berkova; Andrew P Morris; Michael Silberbach; Thomas C Rich
Journal:  J Gen Physiol       Date:  2006-06-12       Impact factor: 4.086

  6 in total
  8 in total

1.  MicroRNA-503 Exacerbates Myocardial Ischemia/Reperfusion Injury via Inhibiting PI3K/Akt- and STAT3-Dependent Prosurvival Signaling Pathways.

Authors:  Yanjing He; Yin Cai; Tianhao Sun; Liangqing Zhang; Michael G Irwin; Aimin Xu; Zhengyuan Xia
Journal:  Oxid Med Cell Longev       Date:  2022-05-17       Impact factor: 7.310

2.  Fibrosis and loss of smooth muscle in the corpora cavernosa precede corporal veno-occlusive dysfunction (CVOD) induced by experimental cavernosal nerve damage in the rat.

Authors:  Monica G Ferrini; Istvan Kovanecz; Sandra Sanchez; Chiome Umeh; Jacob Rajfer; Nestor F Gonzalez-Cadavid
Journal:  J Sex Med       Date:  2008-12-02       Impact factor: 3.802

Review 3.  Extracellular signalling molecules in the ischaemic/reperfused heart - druggable and translatable for cardioprotection?

Authors:  P Kleinbongard; G Heusch
Journal:  Br J Pharmacol       Date:  2014-11-24       Impact factor: 8.739

4.  Tafluprost protects rat retinal ganglion cells from apoptosis in vitro and in vivo.

Authors:  Akiyasu Kanamori; Maiko Naka; Masahide Fukuda; Makoto Nakamura; Akira Negi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-06-24       Impact factor: 3.117

Review 5.  The RISK pathway and beyond.

Authors:  Xavier Rossello; Derek M Yellon
Journal:  Basic Res Cardiol       Date:  2017-11-15       Impact factor: 17.165

6.  Naringenin Attenuates Myocardial Ischemia-Reperfusion Injury via cGMP-PKGIα Signaling and In Vivo and In Vitro Studies.

Authors:  Li-Ming Yu; Xue Dong; Jian Zhang; Zhi Li; Xiao-Dong Xue; Hong-Jiang Wu; Zhong-Lu Yang; Yang Yang; Hui-Shan Wang
Journal:  Oxid Med Cell Longev       Date:  2019-01-08       Impact factor: 6.543

7.  The role of adrenergic and muscarinic receptors in stress-induced cardiac injury.

Authors:  Boris K Kurbatov; Ekaterina S Prokudina; Leonid N Maslov; Natalia V Naryzhnaya; Sergey V Logvinov; Alexander S Gorbunov; Alexandr V Mukhomedzyanov; Andrey V Krylatov; Nikita S Voronkov; Andrey S Sementsov; Konstantin V Zavadovsky; Viktor V Saushkin; Rajendra P Nagarajan; Peter R Oeltgen
Journal:  Pflugers Arch       Date:  2021-07-10       Impact factor: 3.657

8.  CIBER-CLAP (CIBERCV Cardioprotection Large Animal Platform): A multicenter preclinical network for testing reproducibility in cardiovascular interventions.

Authors:  Xavier Rossello; Antonio Rodriguez-Sinovas; Gemma Vilahur; Verónica Crisóstomo; Inmaculada Jorge; Carlos Zaragoza; José L Zamorano; Javier Bermejo; Antonio Ordoñez; Lisardo Boscá; Jesús Vázquez; Lina Badimón; Francisco M Sánchez-Margallo; Francisco Fernández-Avilés; David Garcia-Dorado; Borja Ibanez
Journal:  Sci Rep       Date:  2019-12-30       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.